Home › Research › Tau biomarkers
Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort
Moghekar A, Goh J, Li M, Albert M, O'Brien RJ.. Archives of neurology, 2012-02-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Objective To determine whether cerebrospinal fluid (CSF) biomarkers for Alzheimer disease fluctuate significantly over time in a cohort of older, mildly symptomatic individuals. Design Biomarker validation in a clinical cohort. Setting University hospital inpatient unit.
What this study adds
Evidence grade: Moderate
In ten older patients, cerebrospinal fluid levels of Aβ and tau were measured every 6 hours over 24 or 36 hours to see whether they fluctuate significantly. Reported effect size: 5.5%; 3.8%; 10.0%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Moghekar, A., Goh, J., Li, M., Albert, M., & O'Brien, R. J. (2012). Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort. Archives of neurology. https://doi.org/10.1001/archneurol.2011.732
Vancouver
Moghekar A, Goh J, Li M, Albert M, O'Brien RJ. Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort. Archives of neurology. 2012. doi:10.1001/archneurol.2011.732. PMID: 22332192.
BibTeX
@article{moghekar2012-22332192,
author = {Moghekar, A. and Goh, J. and Li, M. and Albert, M. and O'Brien, R. J.},
title = {{Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort}},
journal = {Archives of neurology},
year = {2012},
doi = {10.1001/archneurol.2011.732},
pmid = {22332192},
url = {https://doi.org/10.1001/archneurol.2011.732}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Design Biomarker validation in a clinical cohort.
- Setting University hospital inpatient unit.
- Participants Ten patients admitted for CSF drainage for diagnostic purposes.
- Main outcome measures The CSF levels of Aβ1-40, Aβ1-42, tau, and phosphorylated tau on threonine 181 (p-tau(181)) were measured every 6 hours for 24 or 36 hours.
Why it matters
In ten older patients, cerebrospinal fluid levels of Aβ and tau were measured every 6 hours over 24 or 36 hours to see whether they fluctuate significantly. This very small study is about how stable these biomarkers are, not about any treatment or prevention.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Effect size5.5%; 3.8%; 10.0%
- Evidence strengthModerate
How this study scored 45/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Archives of neurology) |
| Journal's citation record | 3 / 4 | Archives of Neurology: journal h-index 353 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2012 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 45 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 2.8 citations a year over 16 year(s) since 2012 |
| Impact for its field and year | 3 / 6 | Cited 5.1× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 6 other studies in this library |
| Still being cited | 1 / 4 | Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Abhay Moghekar: h-index 51 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | Johns Hopkins University: institution h-index 2,306 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 22332192) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 45 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1001/archneurol.2011.732
- PubMed: 22332192
- Original source →
- Free full text: PubMed Central →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
6 studies in the alzhub library list this one in their references.
Related studies in Tau biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.